)
)
)
Nocicera Therapeutics
Nocicera is developing somatostatin SSTR4 agonists for the treatment of epilepsy and other CNS disorders. The company's lead assets are at candidate stage and we are seeking investment or strategic partnership to advance the program through clinical trials.
Address
BostonMassachusetts
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)